Pediatrics


Symposium: Retinopathy of prematurity

Thursday, June 18, 1230–1715
Carson A

OBJECTIVES

At the end of this session, participants will be able to:

  • Integrate some of the latest research, particularly on risk factors, into their care of ROP patients
  • Apply new knowledge from the Canadian SCREEN-ROP study, into their care of ROP patients
  • Demonstrate a solid understanding of the pros and cons of anti-VEGF therapy
  • Understand the ethical issues involved in ROP care

GUESTS

Ann Hellström
Alex Levin
Kourosh Sabri

MODERATORS

Jane Gardiner
Anna Ells


Schedule

1230 Introduction · Jane Gardiner
1235 WINROP as a screening tool for ROP · Ann Hellström
1300 Discussion
1310 2nd Prize, COS Award for Excellence in Research
Neurodevelopmental outcomes of preterm infants treated with bevacizumab for severe ROP · J. Morin, R. Superstein, T. Luu, L.H. Ospina, F. Lefebvre, M. Simard, V.Shah, S. Shah, E. Kelly
1317 Review of teleophthalmology screening for ROP at McMaster University · S. Mohaghegh, V. Chaudhary, G. Isaza, J. Barbosa
1324 Discussion
1330 SCREEN-ROP: Part 1 · Kourosh Sabri
1350 Discussion
1400 Omega 3 and insulin growth factor in ROP · Ann Hellström
1420 Discussion
1430 Avastin debate: Pro · Patrick Hamel
1440 Avastin debate: Con · N.N. Tehrani
1450 Discussion
1500 Break
1530 Introduction · Jane Gardiner
1532 To inject or not to inject: Ethics, innovation and ROP · Alex Levin
1547 Discussion
1555 Involution patterns of type 1 ROP after treatment with intravitreal bevacizumab · K. Mireskandari, M. Isaac, N.N. Tehrani
1602 Ranibizumab for treatment of type 1 ROP · J.D. Wesolosky, A. Ells, P. Mitchell
1609 Outcomes following treatment of type 1 ROP with bevacizumab vs. laser: 2-Year follow-up · N.N. Tehrani, M. Isaac, K. Mireskandari
1616 Discussion
1625 SWEDROP: A national register including all children screened for ROP in Sweden since 2004 · Ann Hellström
1640 Discussion
1645 SCREEN-ROP: Part 2 · Kourosh Sabri
1705 Discussion


Canadian Association of Pediatric Ophthalmology and Strabismus

Pediatrics I – Ethics, anterior segment and pediatric ophthalmology poster previews

Friday, June 19, 1045-1215
Carson C

OBJECTIVES

At the end of this session participants will be able to:

  • Understand the issues involved in adopting EMRs
  • Integrate new therapies and updated information of pediatric glaucoma into patient care
  • Become aware of the ethics involved in using novel therapies for unilateral retinoblastoma

GUEST

Alex Levin

MODERATOR

Luis Ospina


Schedule

1045 Introduction
1048 Intracameral use of preservative-free triamcinolone in pediatric cataract · H.A. Khan
1055 A five-year experience of electronic medical records (EMR) in pediatric ophthalmology and strabismus practice · V. Erraguntla, H. Rattanavong, L. Groff
1102 Efficacy and safety of cyclosporine topical eye drops in severe allergic keratoconjunctivitis in children · H.A. Khan, Z. Khouqweer
1109 Ethical considerations of innovative therapy in children with unilateral retinoblastoma · C. McAlister, B.L. Gallie
1116 Discussion
1123 The international childhood glaucoma research network classification and registry · Alex Levin
1138 Discussion
1145 Poster preview introduction (90 seconds per poster)

  • Delayed vitreous hemorrhage: An unusual complication of pediatric cataract surgery · M. Mikhail, N. Braverman, R. Koenenkoop, A. Khan
  • Retinal manifestations in Adams-Oliver syndrome · M.K. Kwok, C. Senger, A. Lehman, C. Lyons
  • Painful acute corneal ulceration and anterior stromal keratitis in a teenager with reactive arthritis (Reiter disease) · E. AlQahtani, J. Gardiner, C. Lyons
  • Unilateral optic nerve hypoplasia and multiple retinochoroidal coloboma in an infant · L. Zhao, G. Isaza
  • Acute disseminated encephalomyelitis with raised intracranial pressure in a pediatric patient: Case report and review of the literature · M. Abtahi, M. O’Connor
  • Leber congenital amaurosis in a mixed Canadian population: Characterization of genotypes and clinical phenotypes · M.P. Perez Araya, E. Héon, A. Vincent
  • Novel PITX2 mutations in Chinese patients with Axenfeld-Rieger syndrome · X. Guo
  • Ocular toxicity in children treated with deferasirox (Exjade) at the Hospital for Sick Children · J.S. Manusow, M. Kirby-Allen, W. Lam
  • Pediatric idiopathic orbital inflammatory syndrome: A case report and review of the literature · S. Wakil, A. Khan
  • Rhino-orbital mucormycosis with ipsilateral orbital inflammatory syndrome, central retinal artery occlusion and contralateral fungal chorioretinitis in a child · C. Law, J. Gale, V. Kratky, Y. Strube


Canadian Association of Pediatric Ophthalmology and Strabismus

Pediatrics II: Strabismus, amblyopia and vision screening

Friday, June 19, 1330–1500
Carson C

OBJECTIVES

At the end of this session participants will be able to:

  • Describe current research in the areas of amblyopia and strabismus
  • Integrate Botox into surgical management of strabismus
  • Integrate AS-OCT into strabismus management
  • Assess examples of Canadian vision screening programs

MODERATOR

Ross Kennedy


Schedule

1330 Introduction
1333 Factors predicting decompensation in children with accommodative esotropia and high AC/A ratio · Y.N. Chen, A. Mao, I. Makar
1340 Botulinum toxin in strabismus · V. Pegado
1347 Factors associated with success in strabismus surgery secondary to thyroid eye disease · I. Golesic, I. Makar
1354 Discussion
1402 Myopia and strabismus: An epidemiological analysis · A. Alhaji, G. Laroche
1409 Pediatric vision screening: How are Ontario primary care physicians doing? · T.D. Le, R.A. Raashid, L. Colpa, J. Noble, A. Ali, A. Wong
1416 An evidence-based assessment of pediatric vision screening by non-eye care professionals: Moving towards evidence-based practice · K. Sabri, S. Husain, S. Tavassoly, R. Wong, Y. Jin, F. Farrokhyar
1423 Discussion
1431 Developmental trajectory of audiovisual integration in children and adults with amblyopia · A. Wong, C. Narinesingh, A. Raashid, H. Goltz
1438 Accuracy of anterior segment optical coherence tomography (AS-OCT) in localising ocular rectus muscles · S. Kraft, C.S. Ngo, D. Smith
1445 Behavioral training as new treatment for adult amblyopia: A meta-analysis and systematic review · A. Wong, I. Tsirlin, L. Colpa, H. Goltz
1452 Discussion


Canadian Association of Pediatric Ophthalmology and Strabismus

Pediatrics III – Pediatric ophthalmology and strabismus for the comprehensive ophthalmologist

Friday, June 19, 1545–1715
Carson C

OBJECTIVES

At the end of this session participants will be able to:

  • Incorporate pediatric eye exam tips into their practice, without missing problems
  • Assess and manage ocular surface disease in the pediatric population
  • Integrate strabismus surgery into their practice
  • Have confidence when dealing with suspected non-accidental injury patients
  • Manage post-cataract and refractive surgery diplopia surprises

MODERATOR

Jane A. Gardiner


Schedule

1545 Introduction
1547 Pediatric eye exam tips and tricks · Michael O’Connor
1556 Discussion
1559 Ocular surface disease: Peculiarities in children · Inas Makar
1608 Discussion
1611 Strategies for strabismus surgery for the comprehensive ophthalmologist · Roy Cline
1631 Discussion
1639 Post-op diplopia surprises after cataract or refractive surgery… 2 quick pre-op tests could have predicted · Robert LaRoche
1648 Discussion
1651 Non-accidental Injury: What the comprehensive ophthalmologist should know · Jane Gardiner
1700 Discussion
1703 Patient with a lazy eye: Check the whole eye · Vasudha Erraguntla
1712 Discussion


Canadian Association of Pediatric Ophthalmology and Strabismus

COS-5 Clinical update: Pediatrics

Saturday, June 20, 1045-1215
Theatre

OBJECTIVES

At the end of this session participants will be able to:

  • Integrate current research on ocular genetics and amblyopia into their practice
  • Assess the risk factors for retinopathy of prematurity
  • Describe the “new science” perpetrated in abusive head trauma legal cases

GUESTS

Ann Hellström
Alex Levin

MODERATOR

Christopher Lyons


Schedule

1045 Introduction · Christopher Lyons
1048 An update on risk factors for ROP · Ann Hellström
1108 When should we think of genetic testing for our patients? · Elise Heon
1125 What’s new and exciting in amblyopia? · Agnes Wong
1145 The “new science” of abusive head trauma · Alex Levin
1200 Discussion